HUMAN POLYOMAVIRUS INFECTION

This adverse event was reported 531 times

HUMAN POLYOMAVIRUS INFECTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CIDOFOVIR ANHYDROUS 13 0.0090
1 BUSULFAN 64 0.0040
2 THIOTEPA 30 0.0031
3 EVEROLIMUS TABLETS 47 0.0027
4 MILTEFOSINE 1 0.0026
5 TACROLIMUS OINTMENT 0.1% 303 0.0024
6 TACROLIMUS EXTENDED-RELEASE CAPSULES 303 0.0024
7 CARMUSTINE 11 0.0023
8 SIROLIMUS 31 0.0023
9 POLATUZUMAB VEDOTIN 22 0.0022
See all drugs enriched for association with HUMAN POLYOMAVIRUS INFECTION